Banimfreg B, Shamayleh A, Alshraideh H
Metabolites. 2022; 12(10).
PMID: 36295904
PMC: 9610953.
DOI: 10.3390/metabo12101002.
Garcia-Campos M, Espinal-Enriquez J, Hernandez-Lemus E
Front Physiol. 2016; 6:383.
PMID: 26733877
PMC: 4681784.
DOI: 10.3389/fphys.2015.00383.
Varma S, Pommier Y, Sunshine M, Weinstein J, Reinhold W
PLoS One. 2014; 9(3):e92047.
PMID: 24670534
PMC: 3966786.
DOI: 10.1371/journal.pone.0092047.
Smith S, Wilson M, Ward J, Rahman C, Peet A, MacArthur D
PLoS One. 2012; 7(12):e52335.
PMID: 23272238
PMC: 3525561.
DOI: 10.1371/journal.pone.0052335.
Roberts J, Escudero C
Pregnancy Hypertens. 2012; 2(2):72-83.
PMID: 22745921
PMC: 3381433.
DOI: 10.1016/j.preghy.2012.01.001.
Drug discovery: Cell lines battle cancer.
Weinstein J
Nature. 2012; 483(7391):544-5.
PMID: 22460893
DOI: 10.1038/483544a.
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.
Huang R, Johnatty S, Gamazon E, Im H, Ziliak D, Duan S
Clin Cancer Res. 2011; 17(16):5490-500.
PMID: 21705454
PMC: 3160494.
DOI: 10.1158/1078-0432.CCR-11-0724.
The reductionist paradox: are the laws of chemistry and physics sufficient for the discovery of new drugs?.
Maggiora G
J Comput Aided Mol Des. 2011; 25(8):699-708.
PMID: 21698487
DOI: 10.1007/s10822-011-9447-8.
Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity.
Gamazon E, Im H, ODonnell P, Ziliak D, Stark A, Cox N
Mol Cancer Ther. 2011; 10(3):472-80.
PMID: 21252287
PMC: 3079551.
DOI: 10.1158/1535-7163.MCT-10-0910.
iCOD: an integrated clinical omics database based on the systems-pathology view of disease.
Shimokawa K, Mogushi K, Shoji S, Hiraishi A, Ido K, Mizushima H
BMC Genomics. 2010; 11 Suppl 4:S19.
PMID: 21143802
PMC: 3005924.
DOI: 10.1186/1471-2164-11-S4-S19.
Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.
Romero R, Mazaki-Tovi S, Vaisbuch E, Kusanovic J, Chaiworapongsa T, Gomez R
J Matern Fetal Neonatal Med. 2010; 23(12):1344-59.
PMID: 20504069
PMC: 3440243.
DOI: 10.3109/14767058.2010.482618.
Multifactorial regulation of E-cadherin expression: an integrative study.
Reinhold W, Reimers M, Lorenzi P, Ho J, Shankavaram U, Ziegler M
Mol Cancer Ther. 2010; 9(1):1-16.
PMID: 20053763
PMC: 2821037.
DOI: 10.1158/1535-7163.MCT-09-0321.
Biomedical ontologies in action: role in knowledge management, data integration and decision support.
Bodenreider O
Yearb Med Inform. 2008; :67-79.
PMID: 18660879
PMC: 2592252.
The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.
Romero R, Espinoza J, Gotsch F, Kusanovic J, Friel L, Erez O
BJOG. 2007; 113 Suppl 3:118-35.
PMID: 17206980
PMC: 7062297.
DOI: 10.1111/j.1471-0528.2006.01150.x.
AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies.
Major S, Nishizuka S, Morita D, Rowland R, Sunshine M, Shankavaram U
BMC Bioinformatics. 2006; 7:192.
PMID: 16600027
PMC: 1524995.
DOI: 10.1186/1471-2105-7-192.
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
Nishizuka S, Charboneau L, Young L, Major S, Reinhold W, Waltham M
Proc Natl Acad Sci U S A. 2003; 100(24):14229-34.
PMID: 14623978
PMC: 283574.
DOI: 10.1073/pnas.2331323100.
GoMiner: a resource for biological interpretation of genomic and proteomic data.
Zeeberg B, Feng W, Wang G, Wang M, Fojo A, Sunshine M
Genome Biol. 2003; 4(4):R28.
PMID: 12702209
PMC: 154579.
DOI: 10.1186/gb-2003-4-4-r28.
MatchMiner: a tool for batch navigation among gene and gene product identifiers.
Bussey K, Kane D, Sunshine M, Narasimhan S, Nishizuka S, Reinhold W
Genome Biol. 2003; 4(4):R27.
PMID: 12702208
PMC: 154578.
DOI: 10.1186/gb-2003-4-4-r27.
